Literature DB >> 23340917

Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis.

Nobuhiro Hanai1, Daisuke Kawakita, Taijiro Ozawa, Hitoshi Hirakawa, Takeshi Kodaira, Yasuhisa Hasegawa.   

Abstract

BACKGROUND: Recently, the role of chemoradiotherapy (CRT) for preserving organs in the treatment of head and neck cancer has been increasing. However, the indication for post-CRT neck dissection (ND) and its surgical extent is still controversial. The purpose of this study was to discuss the indications for post-CRT ND and the proper extent of the surgical procedure.
METHODS: We performed a retrospective analysis on N2-3 oropharyngeal and hypopharyngeal squamous cell carcinoma (OHSCC) patients treated with CRT in our institute from 1995 to 2008, and determined the prognostic impact of post-CRT ND and the distribution of cervical lymph node (CLN) metastasis based on the pathological results of ND.
RESULTS: The patients without pathological CLN metastases had good prognoses, whereas patients with pathological CLN metastases exhibited a significantly high recurrence rate (P = 0.033). Based on the pathological results of ND, performing selective ND at levels II-IV can contain 88 and 85 % of CLN metastasis of the oropharynx and hypopharynx, respectively. In all cases, when pathological CLN metastases were found at level V in ND following CRT, distant metastases developed.
CONCLUSIONS: The presence of pathological CLN metastasis affects prognosis, but also a diffuse distribution of CLN metastasis worsens prognosis; that is, the presence of CLN metastasis at level V after CRT appears to be an indicator of distant metastasis. Post-CRT ND may not make sense as a salvage intervention for improving the prognosis in such situations. We concluded that the proper extent of post-CRT ND of OHSCC is selective ND including levels II-IV.

Entities:  

Mesh:

Year:  2013        PMID: 23340917     DOI: 10.1007/s10147-013-0518-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  28 in total

1.  Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.

Authors:  P Lavertu; D J Adelstein; J P Saxton; M Secic; J R Wanamaker; I Eliachar; B G Wood; M Strome
Journal:  Head Neck       Date:  1997-10       Impact factor: 3.147

Review 2.  Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis.

Authors:  P M Som
Journal:  AJR Am J Roentgenol       Date:  1992-05       Impact factor: 3.959

3.  Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer.

Authors:  K Thomas Robbins; Muthuswamy Dhiwakar; Francisco Vieira; Krishna Rao; James Malone
Journal:  Oral Oncol       Date:  2012-07-15       Impact factor: 5.337

4.  Radical neck dissection: a 19-year experience.

Authors:  A G Maran; M Amin; J A Wilson
Journal:  J Laryngol Otol       Date:  1989-08       Impact factor: 1.469

5.  Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.

Authors:  Susan Urba; Gregory Wolf; Avraham Eisbruch; Francis Worden; Julia Lee; Carol Bradford; Theodoros Teknos; Douglas Chepeha; Mark Prince; Norman Hogikyan; Jeremy Taylor
Journal:  J Clin Oncol       Date:  2005-12-27       Impact factor: 44.544

6.  Planned post-chemoradiation neck dissection: significance of radiation dose.

Authors:  Kerstin M Stenson; Dezheng Huo; Elizabeth Blair; Ezra E W Cohen; Athanassios Argiris; Daniel J Haraf; E Everett Vokes
Journal:  Laryngoscope       Date:  2006-01       Impact factor: 3.325

7.  Clinical outcome following radiotherapy and planned neck dissection in N+ head and neck cancer patients.

Authors:  Alexander Ahlberg; Magnus Lagerlund; Freddi Lewin; Signe Friesland; Jan Lundgren
Journal:  Acta Otolaryngol       Date:  2008       Impact factor: 1.494

8.  Squamous cell carcinoma of the head and neck treated with radiotherapy: does planned neck dissection reduce the change for successful surgical management of subsequent local recurrence?

Authors:  W M Mendenhall; J T Parsons; R J Amdur; N J Cassisi; R R Million
Journal:  Head Neck Surg       Date:  1988 May-Jun

9.  Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.

Authors:  James P Malone; Michael A T Gerberi; Syam Vasireddy; Larry F Hughes; Krishna Rao; Bruce Shevlin; Matthew Kuhn; Dean Collette; Joel Tennenhouse; K Thomas Robbins
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-11

Review 10.  A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.

Authors:  M G Isles; C McConkey; H M Mehanna
Journal:  Clin Otolaryngol       Date:  2008-06       Impact factor: 2.597

View more
  1 in total

1.  Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study.

Authors:  Yujiao Li; Xiaomin Ou; Chaosu Hu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.